The majority of new medical devices are
unsuccessful in the marketplace, often due to biased or off the cuff advice
from physician consultants. The opinions from these consultants are often
flawed because the physician has limited knowledge of the clinical and reimbursement
potential of new medical devices.
MPAnalytics’ medical consultants are
a group of clinically active academic physicians who use analytical processes,
rather than anecdotal information, to predict whether the new product will be
marketable and reimbursable. Decisions based on thorough evaluation of the
product can help predict profitability and commercial
feasibility.
MPAnalytics provides each client with a rating
sheet that assigns an overall rating for your medical product or technology
based on our five key categories below. Based on the results, MPAnalytics
offers consultation for ways to improve these ratings.
Your product’s clinical potential is the
viability of the product in a clinical setting, and gives an assessment of the
product in comparison to similar products when applicable.
Scientific merit assesses the quality and
technological components of the medical product or technology to determine if
these pieces make sense to the market or enhance patient/user experience.
Reimbursement potential is determined by the
use of MPAnalytics’ extensive experience in reimbursement regulations to
determine a rating based on the pro’s and con’s for
your medical product or technology.
MPAnalytics rates your clinical research
trial needs based on the possible requirements for your product for insurance
carriers.
MPAnalytics assigns a market evaluation
rating to your medical product based on their assessment of the best approach
to market, the available market size, and the pro’s and con’s of both.
We assist with the preparation and submission
of NIH, SBIR, and other grant requests. Our experts talk with the reviewers and
can save you considerable time, frustration, and effort with a knowledgeable,
focused approach.
Nothing provides credibility to potential
investors like an objective report by physician experts in the field.
We can assist you through every step of your
FDA requirements – from strategy to final approval.
Our consultants have an in-depth
understanding of physician and facility reimbursement issues and can assist in
developing appropriate strategies to maximize payment for a new medical
product.
Dealing with various government agencies and
obtaining correct codes is of paramount importance in maximizing reimbursement.
This issue is covered in detail in this webinar that can be viewed at the
following address: http://www.clinipace.com/webcast/4approaches-may-7-09/default.html.
MPAnalytics offers comprehensive seminars to
medical device companies to educate the client on the complexities of
introducing a new medical device into the clinical marketplace. This course can
be customized to fit your firm’s needs and can be conducted at your place of
business.
Topics discussed include: